Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 95

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 12
Chunk 95
---
ITEM
12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

  Debt        
  Securities  
 ──────────────

Not
Applicable.

  Warrants    
  and Rights  
 ──────────────

Warrants

Every
two warrants entitle the registered holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as discussed
below. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares. This means that
only an even number of warrants may be exercised at any given time by a warrant holder. However, except as set forth below, no warrants
will be exercisable for cash unless we have an effective and current registration statement covering the ordinary shares issuable upon
exercise of the warrants and a current prospectus relating to such ordinary shares. If an exemption from registration is not available,
holders will not be able to exercise their warrants on a cashless basis. The warrants will expire five years after the completion of
our initial business combination, at 5:00 p. m., New York City time, or earlier upon redemption or liquidation.

We
may call the warrants for redemption, in whole and not in part, at a price of $0.01 per warrant:

  at                                                                                                                                   
  upon                                                                                                                                 
  if,                                                                                                                                  
  if,                                                                                                                                  

The
right to exercise will be forfeited unless the warrants are exercised prior to the date specified in the notice of redemption. On and
after the redemption date, a record holder of a warrant will have no further rights except to receive the redemption price for such holder’s
warrant upon surrender of such warrant.

The
redemption criteria for our warrants have been established at a price which is intended to provide warrant holders a reasonable premium
to the initial exercise price and provide a sufficient differential between the then-prevailing share price and the warrant exercise
price so that if the share price declines as a result of our redemption call, the redemption will not cause the share price to drop below
the exercise price of the warrants.

If
we call the warrants for redemption as described above, our management will have the option to require all holders that wish to exercise
warrants to do so on a “cashless basis.” In such event, each holder would pay the exercise price by surrendering the whole
warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary